Insider Transactions in Q1 2024 at Evolent Health, Inc. (EVH)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2024
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,020
-4.01%
|
$306,680
$34.41 P/Share
|
|
Mar 02
2024
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,830
-2.81%
|
$164,220
$34.41 P/Share
|
|
Mar 02
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
5,638
-2.52%
|
$191,692
$34.41 P/Share
|
|
Mar 01
2024
|
Russell Monroe Glass Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,163
+50.0%
|
-
|
|
Mar 01
2024
|
Emily Ann Rafferty Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,049
-8.89%
|
$239,666
$34.41 P/Share
|
|
Mar 01
2024
|
Emily Ann Rafferty Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,911
+12.09%
|
-
|
|
Mar 01
2024
|
Aammaad Shams Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,569
-4.47%
|
$87,346
$34.41 P/Share
|
|
Mar 01
2024
|
Aammaad Shams Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,491
+11.52%
|
-
|
|
Mar 01
2024
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,213
-4.75%
|
$381,242
$34.41 P/Share
|
|
Mar 01
2024
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,123
+4.88%
|
-
|
|
Mar 01
2024
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,460
-4.16%
|
$253,640
$34.41 P/Share
|
|
Mar 01
2024
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,822
+10.85%
|
-
|
|
Mar 01
2024
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,005
-3.06%
|
$816,170
$34.41 P/Share
|
|
Mar 01
2024
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,096
+3.58%
|
-
|
|
Mar 01
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
13,210
-5.58%
|
$449,140
$34.41 P/Share
|
|
Mar 01
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
19,398
+7.57%
|
-
|
|
Feb 22
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-3.73%
|
$278,223
$33.03 P/Share
|
|
Feb 22
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+10.86%
|
-
|
|
Feb 22
2024
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88,563
-10.5%
|
$2,922,579
$33.03 P/Share
|
|
Feb 22
2024
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
206,209
+19.64%
|
-
|
|
Feb 22
2024
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,006
-8.2%
|
$660,198
$33.03 P/Share
|
|
Feb 22
2024
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+15.28%
|
-
|
|
Feb 22
2024
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,024
-2.49%
|
$132,792
$33.03 P/Share
|
|
Feb 22
2024
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,550
+6.67%
|
-
|